In order to investigate the exact mechanism underlying the increased susceptibility of PAMP-treated DCs to productive infection with X4 virus, we measured the surface expression of HIV-1 coreceptor CXCR4 after exposure to each agonist. The gene discussed is CXCR4; the disease is infection.